Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer

Histopathology

Volumn 35, Issue 1, 1999, Pages 14-18

  Van Diest, P J ^a   Torrenga, H ^a   Borgstein, P J ^a   Pijpers, R ^a   Bleichrodt, R P ^a   Rahusen, F D ^a   Meijer, S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Frozen section; Immunohistochemistry; Imprint cytology; Sentinel lymph node

Indexed keywords

ARTICLE; BREAST CANCER; CANCER STAGING; FEMALE; FROZEN SECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PRIORITY JOURNAL;

ADULT; AGED; BREAST NEOPLASMS; CYTODIAGNOSIS; FEMALE; FROZEN SECTIONS; HUMANS; INTRAOPERATIVE PERIOD; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0032769775     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.1999.00667.x     Document Type: Article

References (24)

1. Krag DN, Meijer SJ, Weaver DT, et al. Minimal access surgery for staging of malignant melanoma. Arch. Surg. 1997; 130; 654-658.
2. Morton DL. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J. Surg. Oncol. 1997; 60; 267-269.
3. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital blue guidance. World J. Surg. 1997; 21; 788-792.
4. Veen H, van der Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br. J. Surg. 1994; 81; 1769-1770.
5. Decesare SL, Fiorica JV, Roberts WS et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel node in vulvar cancer. Gynecol. Oncol. 1997; 66; 425-428.
6. Pettaway CA, Pisters LL, Dinney CP et al. Sentinel lymph node dissection for penile cancer: the MD Anderson Cancer Center experience. J. Urol. 1995; 154; 1999-2003.
7. Lechner P. Probe-guided surgery of colorectal carcinoma. Acta Medica Austriaca 1997; 24; 68-72.
8. Javaheri S, Cruse CW, Stadelman WK, Reintgen DS. Sentinel node excision for the diagnosis of metastatic neuroendocrine carcinoma of the skin: a case report. Ann. Plast. Surg. 1997; 39; 299-302.
9. Lowe FC. Squamous-cell carcinoma of the scrotum. Urol. Clin. N. Am. 1992; 19; 397-405.
10. Giuliano AE, Jones RC, Brennen M, Statman R. Sentinel lymphadenectomy in breast cancer. J. Clin. Oncol. 1997; 15; 2345-2350.
11. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 1993; 2; 335-339.
12. Meijer S. Less axillary node dissection necessary owing to sentinel node biopsy in breast cancer patients. Ned Tijdschr. Geneeskd. 1996; 140; 2219-2243.
13. Uren RF, Howman-Giles RB, Thompson JF et al. Mammary lymphoscintigraphy in breast cancer. J. Nucl. Med. 1995; 16; 1775-1780.
14. Veronesi U, Paganelli G, Galimberti V et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997; 349; 1864-1867.
15. Kissin MW, Quercis della Rovere G, Easton D, Westbury G. Risk of lymphedema following the treatment of breast cancer. Br. J. Surg. 1986; 1; 580-584.
16. Stewart FW, Treves N. Lymphangiosarcoma in postmastectomy lymphedema. Cancer 1948; 1; 64-81.
17. Borgstein PJ, Pijpers R, Comans EFI, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J. Am. Coll. Surg. 1998; 186; 275-283.
18. Pijpers R, Meijer S, Hoekstra OS et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J. Nucl. Med. 1997; 38; 366-368.
19. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349; 1668-1669.
20. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel node hypothesis for breast carcinoma. Ann. Surg. 1997; 226; 271-276.
21. Giuliano AE. Sentinel lymphadenectomy in primary breast carcinoma: an alternative to routine axillary dissection. J. Surg. Oncol. 1996; 62; 75-76.
22. Veronesi U, Zurrida S, Galimberti V. Consequences of sentinel lymph node in clinical decision making in breast cancer and prospects for future studies. Eur. J. Surg. Oncol. 1998; 24; 93-95.
23. Gentry JF. Pelvic lymph node metastases in prostatic carcinoma. The value of touch imprint cytology. Am. J. Surg. Pathol. 1986; 10; 718-727.
24. Hadjiminas DJ, Burke M. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br. J. Surg. 1994; 81; 1615-1616.